Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma
- 31 May 2004
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 44 (2) , 199-211
- https://doi.org/10.1016/j.lungcan.2003.11.017
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Human tumor necrosis factor-α mutant RGD-V29 (F4614) shows potent antitumor activity and reduced toxicity against human tumor xenografted nude miceCancer Letters, 2000
- A new concept in neurodegeneration: TNFα is a silencer of survival signalsTrends in Neurosciences, 2000
- Preferential Activity of Wild‐type and Mutant Tumor Necrosis Factor‐α against Tumor‐derived Endothelial‐like CellsJapanese Journal of Cancer Research, 2000
- RETRACTED: A new mechanism of neurodegeneration: A proinflammatory cytokine inhibits receptor signaling by a survival peptideProceedings of the National Academy of Sciences, 1999
- TNF-α activates at least two apoptotic signaling cascadesOncogene, 1998
- Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell DeathCell, 1996
- TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κBScience, 1996
- An Essential Role for NF-κB in Preventing TNF-α-Induced Cell DeathScience, 1996
- Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation.Journal of Clinical Oncology, 1990
- Trends in Lung Cancer Incidence WorldwideChest, 1989